Buh-Bye Botox Reps!

[anonymous]

A couple of years out of college making 110k/yr tops at this joke of a company, and you banked 200k in two years? Cmon kid you’re embarrassing yourself on here. I’d bet you live in Mommys basement and the 200k is what, Monopoly money? Your PC awards are what Pee Wee playhouse awards? The only thing under your belt is Mr Hand. You damn well best bet your days are numbered. Good luck Asshat clown!!

Hilarious!!!

 

[anonymous]

Abbvie told shareholders they will deleverage $18 billion by 2021. Abbvie will have massive layoffs and RIF/WARN by Q320. Abbvie will SELL off Allergan divisions and keep top line revenue drugs and dump the rest. They will dissect Allergan and lay-off you folks JUST like Ian Read dissected the dozens of company’s and their workforce’s. AbbVie paid for the acquisition with around $60 worth of its own undervalued stock. AbbVies trading at a paltry 7.7 times 2019 earnings. Allergan will bring $23.5 billion in new debt and combined with AbbVie’s existing debt of $35 billion AND an additional $30 billion to finance the merger, total debt will come out to around $90 billion. That load represents 4.5 times EBITDA, a troublesome high ratio for investors. There MUST be layoffs to bring this to fruition. Look what happened Knoll employees AND most Kos employees. Look at Hospira HPD spin which was sold to Pfizer who dismantled it and sold off injectables and the device end to ICU. Look at ADD division dumped. Look at Solvay employees who were let go in mass numbers. Look at TheraSense employees who were axed. Look at Stemcentrx employees axed by Abbvie a few months ago. The list goes ON and ON and the next chapter will be written for YOU!

 

[anonymous]

So what? That’s pharma...thanks

 

[anonymous]

Three is a trio, two is a couple. You just failed pre-k math.

Coming from the dumbass who used "you're" and "your" incorrectly too funny.

 

[anonymous]

Three is a trio, two is a couple. You just failed pre-k math.

Too funny and true.

 

[black]

Neither company look like geniuses in the number department. Such a joke especially with the Botox and Juvederm quotas just released - just blatantly pushing people to leave. Hahahhhhha - beyond unrealistic

 

[OlivJasn]

HI Botox Reps and Sales managers and MSLs! I’m one of the “other” Toxin Reps. Remember how you guys have been stuck-up for years, thinking you all were better than us, walking around all snooty, had doctors in your pocket, laughing at us? Now AbbVie is buying ya, and expect BIG layoffs!

I don’t wish misery on anyone, but karmas a beetch. Enjoy the layoffs and anxiety! Oh, and don’t come running to us, we don’t want Allergan Reps, because you guys are mean! Bye!!!!!

Hi all, I've been working in this field for over 7 years. I can tell you that there is no need to have an argument about the quality of the material or where you work. The main thing is to buy a material that will give a long-lasting effect. Another advantage of synthetic materials: they do not cause allergic reactions, do not contain alien proteins and the body perceives them as an inert material. Synthetic-based fillers do not require testing for allergic reactions. In addition, stable fillers (for this reason they are stable), do not migrate and do not move, although they decrease in volume over time. All materials are not carcinogenic or cause tissue inflammation.You can read more about this here - Combined Botox & Dermal Filler Training Course | Aesthetics Courses. I hope I helped you! Good luck to you!